Gene · 8456
Papers1,428
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,428
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Thymus aging and immune reconstitution, progresses and challenges. | Semin Immunol | 2023 | 37659170 | PubTator, text mining | PubMed |
| Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy. | Front Immunol | 2023 | 37646021 | PubTator, text mining | PubMed |
| Single-cell RNA reveals a tumorigenic microenvironment in the interface zone of human breast tumors. | Breast Cancer Res | 2023 | 37644609 | PubTator, text mining | PubMed |
| Effects of Adding Chitosan on Drug Entrapment Efficiency and Release Duration for Paclitaxel-Loaded Hydroxyapatite-Gelatin Composite Microspheres. | Pharmaceutics | 2023 | 37631239 | PubTator, text mining | PubMed |
| Identifying Cancer Type-Specific Transcriptional Programs through Network Analysis. | Cancers (Basel) | 2023 | 37627195 | PubTator, text mining | PubMed |
| Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts. | Mol Oncol | 2023 | 37604687 | PubTator, text mining | PubMed |
| FOXN Transcription Factors: Regulation and Significant Role in Cancer. | Mol Cancer Ther | 2023 | 37566097 | PubTator, text mining | PubMed |
| Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy. | Nat Metab | 2023 | 37563469 | PubTator, text mining | PubMed |
| Complementarity-determining region clustering may cause CAR-T cell dysfunction. | Nat Commun | 2023 | 37563127 | PubTator, text mining | PubMed |
| Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation. | J Immunother Cancer | 2023 | 37553183 | PubTator, text mining | PubMed |
| MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer. | Cancer Discov | 2023 | 37552839 | PubTator, text mining | PubMed |
| Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc⁻) in colorectal cancer. | Redox Biol | 2023 | 37536085 | PubTator, text mining | PubMed |
| In Vivo Imaging of [60]Fullerene-Based Molecular Spherical Nucleic Acids by Positron Emission Tomography. | Mol Pharm | 2023 | 37531591 | PubTator, text mining | PubMed |
| Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein-Barr Virus LMP1 Protein. | Microorganisms | 2023 | 37512884 | PubTator, text mining | PubMed |
| Small molecule antagonists of PTPmu identified by artificial intelligence-based computational screening block glioma cell migration and growth. | PLoS One | 2023 | 37494327 | PubTator, text mining | PubMed |
| Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model. | Mol Cancer Ther | 2023 | 37487000 | PubTator, text mining | PubMed |
| The mechanism of action and biodistribution of a novel EGFR/VEGF bispecific fusion protein that exhibited superior antitumor activities. | Heliyon | 2023 | 37484224 | PubTator, text mining | PubMed |
| Role of Transcription Factors and MicroRNAs in Regulating Fibroblast Reprogramming in Wound Healing. | J Bioinform Syst Biol | 2023 | 37476502 | PubTator, text mining | PubMed |
| Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo. | Leukemia | 2023 | 37464068 | PubTator, text mining | PubMed |
| Expression Profile and Regulatory Properties of m6A-Modified circRNAs in the Longissimus Dorsi of Queshan Black and Large White Pigs. | Animals (Basel) | 2023 | 37443988 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8456/papers?page=6